Affordable Access

The mutREAD method detects mutational signatures from low quantities of cancer DNA.

Authors
  • Perner, Juliane
  • Abbas, Sujath
  • Nowicki-Osuch, Karol
  • Devonshire, Ginny
  • Eldridge, Matthew
  • Tavaré, Simon
  • Fitzgerald, Rebecca
Publication Date
Jun 19, 2020
Source
Apollo - University of Cambridge Repository
Keywords
Language
English
License
Unknown
External links

Abstract

Abstract Mutational processes acting on cancer genomes can be traced by investigating mutational signatures. Because high sequencing costs limit current studies to small numbers of good-quality samples, we propose a robust, cost- and time-effective method, called mutREAD, to detect mutational signatures from small quantities of DNA, including degraded samples. We show that mutREAD recapitulates mutational signatures identified by whole genome sequencing, and will ultimately allow the study of mutational signatures in larger cohorts and, by compatibility with formalin-fixed paraffin-embedded samples, in clinical settings / The OCCAMS consortium for sample collection and sequencing was funded by a Programme Grant from Cancer Research UK. The laboratory of R.C.F. is funded by a Core Programme Grant from the Medical Research Council (RG84369). We thank the Human Research Tissue Bank, which is supported by the UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, from Addenbrooke’s Hospital. Additional infrastructure support was provided from the Cancer Research UK–funded Experimental Cancer Medicine Centre.

Report this publication

Statistics

Seen <100 times